Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Didanosine vs Continued Zidovudine in HIV Patients with Clinical Deterioration
NCT00002035Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of didanosine in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Status: completed.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002035.